BeOne Medicines Ltd. (ONC) Documents: SEC Filings, Investor Presentations & Press Releases

BeOne Medicines Ltd. (ONC) documents, SEC filings and the IR site together: 156 documents, newest first; latest 2026-08-26. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site

Date	Type	Document
2026-08-26	8-K	Form 8-K, Item 2.02 results
2026-08-05	Press release	BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates
2026-08-05	Deck	Q2 2026 results Clinical trial appendix
2026-08-05	Deck	Q2 2026 results Conference call and webcast for investors and analysts
2026-08-05	8-K	Form 8-K, Item 2.02 results
2026-08-05	10-Q	Form 10-Q for the quarter ended Jun 30
2026-06-26	8-K	Form 8-K, Item 8.01
2026-06-11	8-K	Form 8-K, Item 5.02
2026-06-01	Deck	ASCO 2026 Investor Event Presentation
2026-05-15	8-K	Form 8-K, Item 8.01
2026-05-06	8-K	Form 8-K, Item 2.02 results
2026-05-06	10-Q	Form 10-Q for the quarter ended Mar 31
2026-04-28	Proxy	Definitive proxy statement
2026-04-14	8-K	Form 8-K, Item 2.02 results
2026-02-27	Transcript	Q4 FY25 earnings call transcript
2026-02-26	8-K	Form 8-K, Item 2.02 results
2026-02-26	10-K	Annual report on Form 10-K, FY25
2025-12-19	8-K	Form 8-K, Item 1.02
2025-12-18	8-K	Form 8-K, Item 5.02
2025-11-19	8-K	Form 8-K, Item 1.01
2025-11-06	8-K	Form 8-K, Item 2.02 results
2025-11-06	10-Q	Form 10-Q for the quarter ended Sep 30
2025-08-29	8-K	Form 8-K, Item 2.02 results
2025-08-25	8-K	Form 8-K, Item 1.01
2025-08-06	8-K	Form 8-K, Item 2.02 results
2025-08-06	10-Q	Form 10-Q for the quarter ended Jun 30
2025-05-21	8-K	Form 8-K, Item 5.07
2025-05-13	8-K	Form 8-K, Item 3.02
2025-05-07	8-K	Form 8-K, Item 2.02 results
2025-05-07	10-Q	Form 10-Q for the quarter ended Mar 31
2025-04-29	8-K	Form 8-K, Item 8.01
2025-04-28	8-K	Form 8-K, Item 2.02 results
2025-04-28	8-K	Form 8-K, Item 5.07
2025-04-07	Proxy	Definitive proxy statement
2025-02-28	10-K	Annual report on Form 10-K/A, FY24
2025-02-27	8-K	Form 8-K, Item 2.02 results
2025-02-27	10-K	Annual report on Form 10-K, FY24
2025-01-13	8-K	Form 8-K, Item 7.01
2025-01-08	10-K	Annual report on Form 10-K/A, FY23
2024-12-23	8-K	Form 8-K, Item 8.01

ONC overview · ONC earnings · ONC financials · ONC KPIs · ONC ownership · ONC peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.